Apligraf in the treatment of neuropathic diabetic foot ulcers.

  title={Apligraf in the treatment of neuropathic diabetic foot ulcers.},
  author={Michael E Edmonds},
  journal={The international journal of lower extremity wounds},
  volume={8 1},
This study compared the efficacy and safety of Apligraf (Organogenesis, Inc., Canton, MA) in combination with standard therapy versus standard therapy alone in the treatment of neuropathic diabetic foot ulcers. Efficacy was assessed by time to complete wound healing (by 12 weeks) and incidence of complete wound closure (at 12 weeks). This was an international multi-center, randomized, controlled study. Patients were eligible for entry into the study if the following criteria were met: type 1 or… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 45 extracted citations

The Effect of Wound Dressings on a Bio-Engineered Human Dermo-Epidermal Skin Substitute in a Rat Model.

Journal of burn care & research : official publication of the American Burn Association • 2017


Publications referenced by this paper.
Showing 1-10 of 13 references

Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society • 2006

Sabolinski ML, for the Apligraf Diabetic Foot Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers

A Veves, V Falanga, DG Armstrong
Diabetes Care • 2001

Acute excisional wounds treated with a tissue-engineered skin (Apligraf).

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] • 1999

Evaluation of a collagenalginate topical wound dressing in the management of diabetic foot ulcers

VM Donaghue, JS Chrzan, +3 authors A. Veves
Adv Wound Care • 1998

Similar Papers

Loading similar papers…